In total, over the multi-year life of the plan, the Company expects to incur costs in the range of $185 million to $230 million, which we anticipate will generate approximately $380 million in EBITDA


We now expect adjusted diluted earnings per share* of $0

87, an increase of approximately 9% to 13% from Fiscal Year 2025, compared to our prior guidance of $0


The Company expects to generate revenue in the range of $225 million to $240 million in fiscal year 2026, adjusted EBITDA of $23 million to $26 million, and adjusted earnings per share in the range


We are on track to achieve our targeted SG&A reductions of $200 million in exit rate savings by the end of fiscal year 2027


040 billion, revised from our previous guidance of $1

17, revised from our previous GAAP EPS guidance of $9


System-wide sales are now expected to range from $530 million to $550 million, versus prior guidance of $550 million to $570 million

Consolidated Adjusted EBITDA has been increased to be in the range of $10


The Company now expects 2025 Net Revenues to be flat to down 1% by comparison to 2024 Net Revenues of $3,695 million, Net Income of $294 million to $302 million, Adjusted Net Income of $337 million to


Software revenue in the range of $33
Total revenue in the range of $39
Software revenue in the range of $145


First Quarter Fiscal Year 2027 and Full Fiscal Year 2027 Guidance
Total revenue in the range of $2

Non-GAAP Diluted EPS(3) in the range of ~$0


Outlook unchanged: Serve continues to project an annualized revenue run-rate of $60-$80 million once the 2,000-robot fleet is fully deployed and reaches target utilization, anticipated during 2026

Guidance for Q2: We are guiding to Q2 2025 total revenue in the range of $600 - $700 thousand, representing anticipated growth of approximately 35-60% quarter-over-quarter


perational improvements across the rest of our business, we remain confident that we will achieve - and hopefully exceed - our 2025 revenue target of over $280 million


For the fourth quarter of fiscal 2026 ending June 27, 2026, the Company expects net revenue to be between $427 million to $437 million and non-GAAP EPS to be between $0


The Company expects to generate net income attributable to common shareholders of $0


Full-year 2025 revenue is expected to be $315-$320 million, including $68-$70 million of migrant-related revenue, compared to last quarter's estimate of $300-$330 million

Full-year 2025 adjusted EBITDA2 is expected to be a loss of $25-$28 million, compared to last quarter's estimate of a loss of $20-$30 million

Full-year 2026 revenue is expected to be $280-$300 million, which includes no migrant-related revenue


total bookings growth to resume until the broader tech hiring environment stabilizes, and as a result we are reducing our full-year revenue guidance to $126 to $128 million, with third-quarter revenue


Based on the shipments which slipped from the third quarter to the fourth quarter and the backlog at quarter end, we expect fourth quarter 2025 revenue to be $30 million to $32 million, with gross mar


Adjusted EBITDA in the range of $9
Adjusted EBITDA in the range of $95


We expect full-year 2025 revenue to be in the range of $80 million to $100 million, with a gross margin of approximately 30% to 33%

IPP revenue is anticipated to be between $28 million and $30 million, with a gross margin of approximately 50%

Our DSA segment is expected to contribute between $35 million and $45 million in revenue


In total for multi-year life of the plan, the Company expects to incur costs in the range of $185 million to $230 million, which we anticipate will generate approximately $380 million in EBITDA improv


Total revenue is expected to be between $469 million and $470 million, representing 13

Sales-led subscription revenue is expected to be between $392 million and $393 million, representing 15

Non-GAAP diluted earnings per share is expected to be between $0


For 2026, we continue to expect our investment in property and equipment, net of proceeds from sales, to be within a range of $310


cing FY2025 guidance for Operating Income of $34 billion, Net Income of $24 billion, and Diluted EPS of $80 per share, based on a BTC price outlook of $150,000 at the end of the year," said Andrew Kan

2 billion year-to-date (based on bitcoin price of approximately $118,000 as of July 29, 2025), compared to the newly revised full year 2025 target of $20 billion


On a combined basis, the Company now expects full-year fiscal 2026 net sales of approximately $880 million to $886 million and Adjusted EBITDA of approximately $72 million to $74 million

For the fiscal fourth quarter, Saxdor is expected to contribute net sales of approximately $57 million to $59 million and Adjusted EBITDA margin of 10% to 11%


e estimated fourth quarter impact from the divested Rapid Solutions and New Zealand facilities maintenance businesses included in the prior guidance issued on May 6, 2025 which were approximately: Rev


Charlotte's Web believes it has substantially completed its operating cost reset, and expects quarterly SG&A to remain in a normalized range of approximately $10 million, reflecting a lean, appropriat


It expects revenue from continuing operations to be down mid-to-high teens to approximately $2


The Company expects cash flow from operating activities less cash used for investing activities for 2026 to be in the range of $35 million to $45 million


As such, the Company is raising its target for share repurchases for 2025 to a range of $70 to $90 million, reaffirming its strong commitment to return capital to shareholders


The Company expects to generate strong growth and maintains a revenue target of at least $25 million for 2025

This outlook is supported by results to date and $22


An initial $300 million equity investment is expected to close in the second quarter of 2026, subject to certain conditions, and an additional $250 million equity investment is expected later this yea


The company expects non-GAAP EPS in the range of $3

Full-year 2026 - The company expects revenue of approximately $12

7 billion and non-GAAP EPS in the range of $16


Capital expenditures planned to be in the range of $60 to $70 million


" For Fourth Quarter fiscal 2025 the Company expects: Net revenue to be between $460

For fiscal 2025 the Company now expects: Net revenue to be between $1


Current remaining performance obligations (CRPO), which is contracted and committed revenue expected to be recognized over the next 12 months, was $471 million, up 14% compared to the prior year perio


0 billion, assuming average commodity prices in the range of $370 to $390 per thousand board foot (mbf)


The decrease was expected and primarily the result of $48


"Even with the persistent macro headwinds, we expect to reach our previously conveyed goal of more than $50 million of free cash flow for 2025

We are again reaffirming our prior free cash flow guidance range at $40 million - $70 million


$750 million of total capex is focused on venue expansion and enhancement projects; cash needs for this capex expected to be reduced by approximately $200 million from funding by joint-venture partner

Annual interest expense is expected to be approximately $350 million per annum with a weighted average cost of debt of 4

Accretion expense, primarily related to OCESA, is expected to be approximately $40 million in Q4


For 2025, we expect our investment in property and equipment, net of proceeds from sales, to be within a range of $235


We also increased the guidance range of full year normalized FFO attributable to common stockholders to a range of $4

General and Administrative Expenses: We anticipate general and administrative expenses to be approximately $240 million to $250 million and stock-based compensation expense to be approximately $51 mil

Dispositions: We expect pro rata disposition proceeds of $166 million at a blended yield of 4


Karnival TP-AQ Holdings Limited joint venture (Karnival) equity method investment due to a decision by the Karnival board to terminate the project in Hong Kong and commence windup of the joint venture


Arcus expects to recognize GAAP revenue of between $75 million and $90 million for the full year 2025


We expect October transaction revenue to be approximately $385 million As always, we continue to urge

We expect Q4 subscription and services revenue to be within $710-$790 million


Operations and other costs are expected to be stable to increasing up to $5 million


For the fourth quarter of 2025, Sensata expects revenue of $890 to $920 million, inclusive of recovery of tariff costs, and adjusted EPS of $0

Adjusted Operating Income, Adjusted Net Income, and Adjusted EPS are not expected to be impacted by tariffs, as $12 million of expected tariff revenue would be offset by $12 million in expected relate


Although strong revenue growth was achieved in the third quarter, the Company expects full-year 2025 revenue to be between $716

Based on the strong third quarter performance and the current fourth quarter forecast, the Company now expects its full-year Adjusted EBITDA to be between $86


Fiscal year diluted EPS is still expected to be between $5

Adjusted EPS is still expected to be between $5


Total Revenues: Expected to be between $240 million and $255 million (prior: $235 million to $250 million)


The voluntary quarterly reserve for the first quarter of 2025 under the Company's dividend formula is expected to be $19


pany expects total research and development plus selling, general and administrative expenses to be $380 to $385 million, compared to prior guidance of $370 to $390 million, both estimates excluding a


Third quarter 2025 Adjusted EBITDA is expected to be in a range of $160 million to $170 million

Third quarter Adjusted EPS is expected to be $0

In addition, full-year 2025 expected Adjusted EBITDA excludes estimated depreciation and amortization of approximately $130 million


For the third quarter of fiscal 2025, the Company expects net sales in the range of $370 million to $390 million and adjusted earnings per diluted share in the range of $0

For the fiscal year 2025, in consideration of the Company's year-to-date performance and current visibility to tariff impacts, it now expects net sales in the range of $1

51 billion, adjusted earnings per diluted share in the range of $1


Capital expenditures of approximately $600 million, from its previous expectation of $625 million

Selling, general and administrative expenses of approximately $575 million, from its previous expectation of approximately $600 million

2 billion, from its previous expectation of approximately $1


Non-GAAP Financial Outlook (excluding the impact of approximately $47 million of stock-based compensation and including approximately $3 million of additional income taxes):


Full year 2025 revenue is expected to be $172


In fiscal 2026, we still expect to deliver between 14,000 and 15,000 lots, generating $1


Management reaffirmed its full-year 2025 Adjusted EBITDA guidance range of $93


Our outlook translates to Adjusted EBITDA of $2


" Business Outlook The Company expects its total revenues to be between $295 million and $310 million in the third quarter of 2025


Caris Life Sciences reaffirms its guidance for full year 2026 revenue to be in the range of $1


The Company reiterated its long-term target of $45-$50 million in Adjusted EBITDA1 for FY 2027 and expressed confidence in delivering the strongest annual sales in Company history in 2025


For Q2 2026, we anticipate the gross cost of the Dasher7 gas relief program to be over $50 million, which we expect to fund at least partially by adjusting investment in other areas


Outlook for 2025 We are introducing our 2025 earnings guidance and expect to report net income attributable to common stockholders in a range of $1

General and Administrative Expenses: We anticipate general and administrative expenses to be approximately $235 million to $245 million and stock-based compensation expense to be approximately $49 mil

Dispositions: We expect pro rata disposition proceeds of $516 million at a blended yield of 7


For fiscal year 2025, Select Medical expects revenue to be in the range of $5

5 billion, Adjusted EBITDA to be in the range of $510

0 million, and fully diluted earnings per share to be in the range of $1


Total Revenues: Expected growth of 15% to 20%, with total revenues between $285 million and $300 million


6 in 2023, but below our anticipated range of $235

For 2025, we expect our investment in property and equipment, net of proceeds from sales, to be within a range of $265


For the full year 2025, we expect Adjusted diluted earnings per share to be between $9


The company expects net revenue in the third quarter of 2025 to be approximately $115 million to $135 million


" For the fourth quarter of 2025, the Company expects GAAP revenue of approximately $253 million to $257 million

The Company expects Adjusted EBITDA to be in the range of $62 million to $65 million and Adjusted Diluted EPS to be in the range of $0

For the full year 2025, the Company expects GAAP revenue of approximately $975 million to $979 million


We expect to return at least $1
We expect to return at least $1
We expect to return at least $1


Adjusted operating expenses2 in 2026 are expected to be in the range of $838 to $853 million, down from $864 to $879 million

The guidance excludes the expected amortization of acquired intangible assets of $63 million; the company adjusts for this amount in its non-GAAP reconciliation

Reaffirms depreciation and amortization expense for 2026 is expected to be in the range of $56 to $60 million, excluding the expected amortization of acquired intangible assets


Adjusted EBITDA margin for the fourth quarter is expected to be approximately 22% which includes the impact of approximately $6 million U

Non-GAAP diluted earnings per share are expected to be in the range of $4

Free Cash Flow for the full year 2025 is expected to be greater than $800 million


The company expects first quarter fiscal 2026 revenue to be in the range of $760 to $785 million

The company expects to report earnings per share of between $0


The Company continues to focus on stabilizing the business and plans for sales to be in the range of $255 million to $270 million


" "Turning to our outlook, we expect revenue in fiscal Q2 to be between $270 and $280 million, and Adjusted EBITDA to be between $19 and $20 million


Total Revenues: Expected to be between $240 million and $255 million


Caris Life Sciences expects full year 2025 revenue to be in the range of $675


The increase relates to current tax expense expected to be incurred in relation to recording in full the $375


Fourth Quarter 2025 Outlook: Revenue of $174


Interest expense for the year is expected to be approximately $62 million to $66 million

Diluted weighted average shares outstanding for the year are expected to be approximately 45.0 million to 46

Capital expenditures for the year are expected to be approximately $60 million to $70 million, including approximately $52 million to $62 million of capitalized software development costs


For 2025, Aurinia expects total revenue in the range of $250 million to $260 million and net product sales in the range of $240 million to $250 million


The Company is providing second quarter 2026 revenue guidance to be in the range of $106 million to $108 million and reiterating the full year 2026 guidance provided at our Investor Day in December 20


nnualized homecare revenue per weighted average direct sales representative in Q3 FY 2025 was $1,028,000, slightly higher than Electromed's target range of $900,000 to $1,000,000


For the fiscal year ending January 31, 2027, management expects revenues of $1

Its outlook for net income is between $242 million and $248 million, resulting in net income of $2

Management expects Adjusted EBITDA of $625 million to $633 million


Q1 capital expenditures totaled $249 million; full year spend expected to be $1

Venue investment cash requirements expected to be reduced by approximately $250 million from funding by joint-venture partners, sponsorship agreements, and other sources

Net interest expense is expected to be $280 million


0 billion, assuming average commodity prices in the range of $375 to $425 per thousand board foot (mbf)

Total capital expenditures in the range of $300 million to $350 million


Current remaining performance obligations (CRPO), which is contracted and committed revenue expected to be recognized over the next 12 months, was $451 million, up 14% compared to the prior year perio


The Company currently expects third quarter 2025 Adjusted EBITDA to range between $70 million and $80 million, with an assumed range of average total retail fuel margin from 42


global economic conditions, and ongoing uncertainty associated with geopolitical and supply chain challenges, Koppers is revising its sales forecast to be approximately $1

Accordingly, Koppers is tightening its 2025 financial forecast for adjusted EBITDA to be approximately $255 million to $260 million and adjusted EPS of approximately $4


For the full year 2025, we expect Adjusted diluted earnings per share to be between $9


" "Turning to our outlook, we expect revenue in fiscal Q4, to be between $350 and $370 million, up sequentially to yet another new quarterly record, and implying at least 34% growth year-over-year

We expect adjusted EBITDA to be between $37 and $43 million, also up sequentially to yet another new quarterly record, reflecting continued margin expansion, and implying at least 67


We expect revenue to be in the range of $510 million to $520 million from a previous range of $545 million to $559 million

We expect Adjusted EBITDA to be in the range of $125 million to $135 million


For fiscal year 2025, Select Medical expects revenue to be in the range of $5

5 billion, Adjusted EBITDA to be in the range of $510

0 million, and fully diluted earnings per share to be in the range of $1


The Company anticipates fiscal 2026revenue in the range of $185 million to $200 million, adjusted EBITDA of $15 million to $19 million, and adjusted earnings per share in the range of $0


Revenue is expected to be in the range of $5

Adjusted EBITDA is expected to be in the range of $555 million to $575 million


Third Quarter 2025 Outlook: Revenue of $163


The company expects fourth-quarter revenue to be between $200 to $215 million


For 2026, we continue to expect our investment in property and equipment, net of proceeds from sales, to be between $310


The Company expects to deploy approximately $1 billion of additional invested capital by mid-2026 using existing debt capacity, targeting a second quarter exit quarterly AFFO run rate of $0


" "Turning to our new outlook, which of course includes HomeBuddy, we expect total revenue in fiscal Q3, to be between $330 and $340 million, and total adjusted EBITDA to be between $26

We expect total revenue in full fiscal year 2026, which ends in June, to be between $1


Based on the work currently completed at Chinchillas, SSR Mining expects that 2026 silver production at Puna will be between 7 and 8 million ounces, an increase against the 2023 Puna TRS


Fiscal year 2026 business outlook compared to 2025 exchange rates is approximately $8

Fiscal Q3 2026 business outlook compared to 2025 exchange rates is approximately $0


"Skechers delivered exceptional results in 2024 and exceeded our expectations on a constant currency basis with full year sales of $9


The Company continues to expect full-year 2025 adjusted EBITDA of $1


Capital expenditures planned to be in the range of $125 to $135 million


We are, however, now targeting an Operating Loss below $60 million, down from the previously issued guidance of $70-80 million


Net proceeds from the transaction after closing costs and taxes are anticipated to be approximately $140

its fiscal year 2026 revenue guidance and is now calling for revenue of $857 million to $860 million and is maintaining its adjusted EBITDA guidance of approximately $175 million


Consolidated revenues in the range of $33


Interest expense for the year is expected to be approximately $66 million to $70 million

Fully diluted shares for the year are expected to be approximately 48.5 million to 49

Capital expenditures for the year are expected to be approximately $55 million to $65 million, including approximately $50 million to $60 million of capitalized software development costs


The net income guidance range has been revised from the Company's prior outlook primarily to reflect the $100 million gain recognized during the third quarter of 2025 on the fair value remeasurement o


7 million and above the range of the second quarter of fiscal 2026 guidance of $870 million to $910 million

Net sales in the range of $920M to $960M


System-wide sales are expected to be between $550 million and $570 million, compared to $530

Consolidated Adjusted EBITDA is expected to be between $10


Above guidance ranges include estimated incremental costs related to tariffs (net of expected mitigation efforts) on our expected first quarter results, ranging between $9 million to $11 million befor